Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2006;306:27–66. doi: 10.1007/3-540-29916-5_2

Immunomodulatory Properties of Defensins and Cathelicidins

D M E Bowdish 2, D J Davidson 2, R E W Hancock 2
Editor: William M Shafer1
PMCID: PMC7121507  PMID: 16909917

Abstract

Host defence peptides are a conserved component of the innate immune response in all complex life forms. In humans, the major classes of host defence peptides include the α- and β-defensins and the cathelicidin, hCAP-18/LL-37. These peptides are expressed in the granules of neutrophils and by a wide variety of tissue types. They have many roles in the immune response including both indirect and direct antimicrobial activity, the ability to act as chemokines as well as induce chemokine production leading to recruitment of leukocytes to the site of infection, the promotion of wound healing and an ability to modulate adaptive immunity. It appears that many of these properties are mediated though direct interaction of peptides with the cells of the innate immune response including monocytes, dendritic cells, T cells and epithelial cells. The importance of these peptides in immune responses has been demonstrated since animals defective in the expression of certain host defence peptides showgreater susceptibility to bacterial infections. In the very few instances in which human patients have been demonstrated to have defective host defence peptide expression, these individuals suffer from frequent infections. Although studies of the immunomodulatory properties of these peptides are in their infancy, there is a growing body of evidence suggesting that the immunomodulatory properties of these small, naturally occurring molecules might be harnessed for development as novel therapeutic agents.

Keywords: Antimicrobial Peptide, Paneth Cell, Immunomodulatory Property, Bronchiolitis Obliterans Syndrome, Airway Surface Liquid

Contributor Information

William M. Shafer, Email: wshafer@emory.edu

D. M. E. Bowdish, Email: bob@cmdr.ubc.ca

References

  1. Aarbiou J., Ertmann M., van Wetering S., van Noort P., Rook D., Rabe K.F., Litvinov S.V., van Krieken J.H., de Boer W.I., Hiemstra P.S. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol. 2002;72:167–174. [PubMed] [Google Scholar]
  2. Aarbiou J., Verhoosel R.M., Van Wetering S., De Boer W.I., Van Krieken J.H., Litvinov S.V., Rabe K.F., Hiemstra P.S. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol. 2004;30:193–201. doi: 10.1165/rcmb.2002-0267OC. [DOI] [PubMed] [Google Scholar]
  3. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086–3093. [PubMed] [Google Scholar]
  4. An L.L., Yang Y.H., Ma X.T., Lin Y.M., Li G., Song Y.H., Wu K.F. LL-37 enhances adaptive immune response in murine model challenged with tumour cells. Leuk Res. 2004;29:535–543. doi: 10.1016/j.leukres.2004.11.009. [DOI] [PubMed] [Google Scholar]
  5. Aragon A.S., Pereira H.A., Baca O.G. A cationic antimicrobial peptide enhances the infectivity of Coxiella burnetii. Acta Virol. 1995;39:223–226. [PubMed] [Google Scholar]
  6. Ashitani J., Mukae H., Hiratsuka T., Nakazato M., Kumamoto K., Matsukura S. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest. 2002;121:519–526. doi: 10.1378/chest.121.2.519. [DOI] [PubMed] [Google Scholar]
  7. Baconnais S., Tirouvanziam R., Zahm J.M., de Bentzmann S., Peault B., Balossier G., Puchelle E. Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts. Am J Respir Cell Mol Biol. 1999;20:605–611. doi: 10.1165/ajrcmb.20.4.3264. [DOI] [PubMed] [Google Scholar]
  8. Bals R., Goldman M.J., Wilson J.M. Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun. 1998;66:1225–1232. doi: 10.1128/iai.66.3.1225-1232.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bals R., Wang X., Wu Z., Freeman T., Bafna V., Zasloff M., Wilson J.M. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest. 1998;102:874–880. doi: 10.1172/JCI2410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bals R., Wang X., Zasloff M., Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lungwhere it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A. 1998;95:9541–9546. doi: 10.1073/pnas.95.16.9541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., Wilson J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun. 1999;67:6084–6089. doi: 10.1128/iai.67.11.6084-6089.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811. doi: 10.1146/annurev.immunol.18.1.767. [DOI] [PubMed] [Google Scholar]
  13. Becker M.N., Diamond G., Verghese M.W., Randell S.H. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem. 2000;275:29731–29736. doi: 10.1074/jbc.M000184200. [DOI] [PubMed] [Google Scholar]
  14. Befus A.D., Mowat C., Gilchrist M., Hu J., Solomon S., Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol. 1999;163:947–953. [PubMed] [Google Scholar]
  15. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., Forssmann W.G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995;368:331–335. doi: 10.1016/0014-5793(95)00687-5. [DOI] [PubMed] [Google Scholar]
  16. Biragyn A., Surenhu M., Yang D., Ruffini P.A., Haines B.A., Klyushnenkova E., Oppenheim J.J., Kwak L.W. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol. 2001;167:6644–6653. doi: 10.4049/jimmunol.167.11.6644. [DOI] [PubMed] [Google Scholar]
  17. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 2002;298:1025–1029. doi: 10.1126/science.1075565. [DOI] [PubMed] [Google Scholar]
  18. Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y.J., O’Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med. 2003;197:101–109. doi: 10.1084/jem.20021908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bowdish D.M.E., Davidson D.J., Speert D.P., Hancock R.E.W. The Human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol. 2004;172:3758–3765. doi: 10.4049/jimmunol.172.6.3758. [DOI] [PubMed] [Google Scholar]
  20. Bowdish D.M., Davidson D.J., Lau Y.E., Lee K., Scott M.G., Hancock R.E. Impact of LL-37 on anti-infective immunity. J Leukoc Biol. 2005;77:451–459. doi: 10.1189/jlb.0704380. [DOI] [PubMed] [Google Scholar]
  21. Brogden K.A., Heidari M., Sacco R.E., Palmquist D., Guthmiller J.M., Johnson G.K., Jia H.P., Tack B.F., McCray P.B. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol. 2003;18:95–99. doi: 10.1034/j.1399-302x.2003.00047.x. [DOI] [PubMed] [Google Scholar]
  22. Buhimschi I.A., Jabr M., Buhimschi C.S., Petkova A.P., Weiner C.P., Saed G.M. The novel antimicrobial peptide beta3-defensin is produced by the amnion: a possible role of the fetalmembranes in innate immunity of the amniotic cavity. Am J Obstet Gynecol. 2004;191:1678–1687. doi: 10.1016/j.ajog.2004.03.081. [DOI] [PubMed] [Google Scholar]
  23. Butmarc J., Yufit T., Carson P., Falanga V. Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen. 2004;12:439–443. doi: 10.1111/j.1067-1927.2004.12405.x. [DOI] [PubMed] [Google Scholar]
  24. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N’Guyen T., Thieblemont N., Delneste Y. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood. 2004;104:1778–1783. doi: 10.1182/blood-2003-08-2820. [DOI] [PubMed] [Google Scholar]
  25. Chaly Y.V., Paleolog E.M., Kolesnikova T.S., Tikhonov I.I., Petratchenko E.V., Voitenok N.N. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw. 2000;11:257–266. [PubMed] [Google Scholar]
  26. Chen C.I., Schaller-Bals S., Paul K.P., Wahn U., Bals R. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros. 2004;3:45–50. doi: 10.1016/j.jcf.2003.12.008. [DOI] [PubMed] [Google Scholar]
  27. Chertov O., Michiel D.F., Xu L., Wang J.M., Tani K., Murphy W.J., Longo D.L., Taub D.D., Oppenheim J.J. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935–2940. doi: 10.1074/jbc.271.6.2935. [DOI] [PubMed] [Google Scholar]
  28. Chung W.O., Dale B.A. Innateimmune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun. 2004;72:352–358. doi: 10.1128/IAI.72.1.352-358.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ciornei C.D., Egesten A., Bodelsson M. Effects of humancathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol Scand. 2003;47:213–220. doi: 10.1034/j.1399-6576.2003.00045.x. [DOI] [PubMed] [Google Scholar]
  30. Cole A.M., Dewan P., Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun. 1999;67:3267–3275. doi: 10.1128/iai.67.7.3267-3275.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Cole A.M., Tahk S., Oren A., Yoshioka D., Kim Y.H., Park A., Ganz T. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol. 2001;8:1064–1069. doi: 10.1128/CDLI.8.6.1064-1069.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cole A.M., Liao H.I., Stuchlik O., Tilan J., Pohl J., Ganz T. Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol. 2002;169:6985–6991. doi: 10.4049/jimmunol.169.12.6985. [DOI] [PubMed] [Google Scholar]
  33. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., Holtz D.O., Jenkins A., Na H., Zhang L., Wagner D.S., Katsaros D., Caroll R., Coukos G. Tumor-infiltrating dendritic cell precursors recruited by a betadefensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med. 2004;10:950–958. doi: 10.1038/nm1097. [DOI] [PubMed] [Google Scholar]
  34. Cunliffe R.N., Rose F.R., Keyte J., Abberley L., Chan W.C., Mahida Y.R. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut. 2001;48:176–185. doi: 10.1136/gut.48.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Daher K.A., Selsted M.E., Lehrer R.I. Direct inactivation of viruses by human granulocyte defensins. J Virol. 1986;60:1068–1074. doi: 10.1128/jvi.60.3.1068-1074.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Davidson D.J., Currie A.J., Reid G.S., Bowdish D.M., MacDonald K.L., Ma R.C., Hancock R.E., Speert D.P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172:1146–1156. doi: 10.4049/jimmunol.172.2.1146. [DOI] [PubMed] [Google Scholar]
  37. De Jong E.C., Vieira P.L., Kalinski P., Schuitemaker J.H., Tanaka Y., Wierenga E.A., Yazdanbakhsh M., Kapsenberg M.L. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J Immunol. 2002;168:1704–1709. doi: 10.4049/jimmunol.168.4.1704. [DOI] [PubMed] [Google Scholar]
  38. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069–1074. doi: 10.1084/jem.192.7.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Dhaliwal W., Bajaj-Elliott M., Kelly P. Intestinal defensin gene expression in human populations. Mol Immunol. 2003;40:469–475. doi: 10.1016/s0161-5890(03)00156-1. [DOI] [PubMed] [Google Scholar]
  40. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol. 2001;117:91–97. doi: 10.1046/j.1523-1747.2001.01340.x. [DOI] [PubMed] [Google Scholar]
  41. Duits L.A., Nibbering P.H., van Strijen E., Vos J.B., Mannesse-Lazeroms S.P., van Sterkenburg M.A., Hiemstra P.S. Rhinovirus increases human beta-defensin-2 and-3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol. 2003;38:59–64. doi: 10.1016/S0928-8244(03)00106-8. [DOI] [PubMed] [Google Scholar]
  42. Duits L.A., Ravensbergen B., Rademaker M., Hiemstra P.S., Nibbering P.H. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology. 2002;106:517–525. doi: 10.1046/j.1365-2567.2002.01430.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Durr M., Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun. 2002;70:6515–6517. doi: 10.1128/IAI.70.12.6515-6517.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Elssner A., Duncan M., Gavrilin M., Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol. 2004;172:4987–4994. doi: 10.4049/jimmunol.172.8.4987. [DOI] [PubMed] [Google Scholar]
  45. Emes R.D., Goodstadt L., Winter E.E., Ponting C.P. Comparison of the genomes of human and mouse lays the foundation of genome zoology. Hum Mol Genet. 2003;12:701–709. doi: 10.1093/hmg/ddg078. [DOI] [PubMed] [Google Scholar]
  46. Erdag G., Morgan J.R. Interleukin-1 alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg. 2002;235:113–124. doi: 10.1097/00000658-200201000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fahlgren A., Hammarstrom S., Danielsson A., Hammarstrom M.L. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol. 2003;131:90–101. doi: 10.1046/j.1365-2249.2003.02035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fleischmann J., Selsted M.E., Lehrer R.I. Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages. Diagn Microbiol Infect Dis. 1985;3:233–242. doi: 10.1016/0732-8893(85)90035-5. [DOI] [PubMed] [Google Scholar]
  49. Fritz J.H., Brunner S., Birnstiel M.L., Buschle M., Gabain A., Mattner F., Zauner W. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine. 2004;22:3274–3284. doi: 10.1016/j.vaccine.2004.03.007. [DOI] [PubMed] [Google Scholar]
  50. Frye M., Bargon J., Dauletbaev N., Weber A., Wagner T.O., Gropp R. Expression of human alpha-defensin 5 (HD5) mRNA in nasal and bronchial epithelial cells. J Clin Pathol. 2000;53:770–773. doi: 10.1136/jcp.53.10.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Frye M., Bargon J., Lembcke B., Wagner T.O., Gropp R. Differential expression of human alpha-and beta-defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest. 2000;30:695–701. doi: 10.1046/j.1365-2362.2000.00696.x. [DOI] [PubMed] [Google Scholar]
  52. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ganz T., Metcalf J.A., Gallin J.I., Boxer L.A., Lehrer R.I. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and “specific” granule deficiency. J Clin Invest. 1988;82:552–556. doi: 10.1172/JCI113631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Garcia J.R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., Forssmann W.G. Human betadefensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001;15:1819–1821. [PubMed] [Google Scholar]
  55. Giacometti A., Cirioni O., Ghiselli R., Mocchegiani F., D’Amato G., Circo R., Orlando F., Skerlavaj B., Silvestri C., Saba V., Zanetti M., Scalise G. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am J Respir Crit Care Med. 2004;169:187–194. doi: 10.1164/rccm.200307-971OC. [DOI] [PubMed] [Google Scholar]
  56. Grutkoski P.S., Graeber C.T., Lim Y.P., Ayala A., Simms H.H. Alpha-defensin 1 (human neutrophilprotein 1) as an antichemotactic agent for human polymer phonuclear leukocytes. Antimicrob Agents Chemother. 2003;47:2666–2668. doi: 10.1128/AAC.47.8.2666-2668.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Guo C.J., Tan N., Song L., Douglas S.D., Ho W.Z. Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines. Aids. 2004;18:1217–1218. doi: 10.1097/00002030-200405210-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Halmerbauer G., Arri S., Schierl M., Strauch E., Koller D.Y. The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis. Clin Exp Allergy. 2000;30:1771–1776. doi: 10.1046/j.1365-2222.2000.00988.x. [DOI] [PubMed] [Google Scholar]
  59. Harder J., Bartels J., Christophers E., Schroder J.M. A peptide antibiotic from human skin. Nature. 1997;387:861. doi: 10.1038/43088. [DOI] [PubMed] [Google Scholar]
  60. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276:5707–5713. doi: 10.1074/jbc.M008557200. [DOI] [PubMed] [Google Scholar]
  61. Hase K., Murakami M., Iimura M., Cole S.P., Horibe Y., Ohtake T., Obonyo M., Gallo R.L., Eckmann L., Kagnoff M.F. Expression of LL-37 by human gastric epithelial cells as a potential host defensemechanism againstHelicobacter pylori. Gastroenterology. 2003;125:1613–1625. doi: 10.1053/j.gastro.2003.08.028. [DOI] [PubMed] [Google Scholar]
  62. Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sorensen O., Borregaard N., Stahle-Backdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol. 2003;120:379–389. doi: 10.1046/j.1523-1747.2003.12069.x. [DOI] [PubMed] [Google Scholar]
  63. Hieshima K., Ohtani H., Shibano M., Izawa D., Nakayama T., Kawasaki Y., Shiba F., Shiota M., Katou F., Saito T., Yoshie O. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol. 2003;170:1452–1461. doi: 10.4049/jimmunol.170.3.1452. [DOI] [PubMed] [Google Scholar]
  64. Hiratsuka T., Mukae H., Iiboshi H., Ashitani J., Nabeshima K., Minematsu T., Chino N., Ihi T., Kohno S., Nakazato M. Increased concentrations of human betadefensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Thorax. 2003;58:425–430. doi: 10.1136/thorax.58.5.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Hornef M.W., Frisan T., Vandewalle A., Normark S., Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med. 2002;195:559–570. doi: 10.1084/jem.20011788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Hoshino K., Ogawa K., Hishitani T., Kitazawa R. Influence of heart surgery on magnesium concentrations in pediatric patients. Pediatr Int. 2003;45:39–44. doi: 10.1046/j.1442-200x.2003.01667.x. [DOI] [PubMed] [Google Scholar]
  67. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med. 2001;7:180–185. doi: 10.1038/84627. [DOI] [PubMed] [Google Scholar]
  68. Jones D.E., Bevins C.L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem. 1992;267:23216–23225. [PubMed] [Google Scholar]
  69. Jones D.E., Bevins C.L. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the humanbowel. FEBS Lett. 1993;315:187–192. doi: 10.1016/0014-5793(93)81160-2. [DOI] [PubMed] [Google Scholar]
  70. Kelly P., Feakins R., Domizio P., Murphy J., Bevins C., Wilson J., McPhail G., Poulsom R., Dhaliwal W. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol. 2004;135:303–309. doi: 10.1111/j.1365-2249.2004.02374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Kirikae T., Hirata M., Yamasu H., Kirikae F., Tamura H., Kayama F., Nakatsuka K., Yokochi T., Nakano M. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide againstmurine endotoxemia. Infect Immun. 1998;66:1861–1868. doi: 10.1128/iai.66.5.1861-1868.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., Issbrucker K., Unterberger P., Zaiou M., Lebherz C., Karl A., Raake P., Pfosser A., Boekstegers P., Welsch U., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111:1665–1672. doi: 10.1172/JCI17545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Krisanaprakornkit S., Kimball J.R., Weinberg A., Darveau R.P., Bainbridge B.W., Dale B.A. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun. 2000;68:2907–2915. doi: 10.1128/iai.68.5.2907-2915.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Krisanaprakornkit S., Kimball J.R., Dale B.A. Regulation of humanbeta-defensin-2 in gingival epithelial cells: the involvement of mitogen-activated protein kinase pathways, but not the NF-kappaB transcription factor family. J Immunol. 2002;168:316–324. doi: 10.4049/jimmunol.168.1.316. [DOI] [PubMed] [Google Scholar]
  75. Kumar J., Okada S., Clayberger C., Krensky A.M. Granulysin: a novel antimicrobial. Expert Opin Investig Drugs. 2001;10:321–329. doi: 10.1517/13543784.10.2.321. [DOI] [PubMed] [Google Scholar]
  76. Lala A., Lindemann R.A., Miyasaki K.T. The differential effects of polymorphonuclear leukocyte secretion on human natural killer cell activity. Oral Microbiol Immunol. 1992;7:89–95. doi: 10.1111/j.1399-302x.1992.tb00515.x. [DOI] [PubMed] [Google Scholar]
  77. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000;1:311–316. doi: 10.1038/79758. [DOI] [PubMed] [Google Scholar]
  78. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001;106:263–266. doi: 10.1016/s0092-8674(01)00455-x. [DOI] [PubMed] [Google Scholar]
  79. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995;63:1291–1297. doi: 10.1128/iai.63.4.1291-1297.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Larrick J.W., Hirata M., Zheng H., Zhong J., Bolin D., Cavaillon J.M., Warren H.S., Wright S.C. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol. 1994;152:231–240. [PubMed] [Google Scholar]
  81. Larrick J.W., Lee J., Ma S., Li X., Francke U., Wright S.C., Balint R.F. Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett. 1996;398:74–80. doi: 10.1016/s0014-5793(96)01199-4. [DOI] [PubMed] [Google Scholar]
  82. Lau Y.E., Rozek A., Scott M.G., Goosney D.L., Davidson D.J., Hancock R.E. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun. 2005;73:583–591. doi: 10.1128/IAI.73.1.583-591.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Lehrer R.I., Ganz T. Defensins of vertebrate animals. Curr Opin Immunol. 2002;14:96–102. doi: 10.1016/s0952-7915(01)00303-x. [DOI] [PubMed] [Google Scholar]
  84. Lehrer R.I., Ganz T., Szklarek D., Selsted M.E. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest. 1988;81:1829–1835. doi: 10.1172/JCI113527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Levy O., Ooi C.E., Elsbach P., Doerfler M.E., Lehrer R.I., Weiss J. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J Immunol. 1995;154:5403–5410. [PubMed] [Google Scholar]
  86. Lillard J.W., Jr, Boyaka P.N., Chertov O., Oppenheim J.J., McGhee J.R. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci U S A. 1999;96:651–656. doi: 10.1073/pnas.96.2.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Liu L., Roberts A.A., Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol. 2003;170:575–580. doi: 10.4049/jimmunol.170.1.575. [DOI] [PubMed] [Google Scholar]
  88. Liu Y.J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106:259–262. doi: 10.1016/s0092-8674(01)00456-1. [DOI] [PubMed] [Google Scholar]
  89. Maxwell A.I., Morrison G.M., Dorin J.R. Rapid sequence divergence in mammalian beta-defensins by adaptive evolution. Mol Immunol. 2003;40:413–421. doi: 10.1016/s0161-5890(03)00160-3. [DOI] [PubMed] [Google Scholar]
  90. Medzhitov R., Janeway C., Jr Innate immunity. N Engl J Med. 2000;343:338–344. doi: 10.1056/NEJM200008033430506. [DOI] [PubMed] [Google Scholar]
  91. Morrison G., Kilanowski F., Davidson D., Dorin J. Characterization of the mouse beta defensin 1, defb1, mutant mouse model. Infect Immun. 2002;70:3053–3060. doi: 10.1128/IAI.70.6.3053-3060.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Moser C., Weiner D.J., Lysenko E., Bals R., Weiser J.N., Wilson J.M. Beta-defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun. 2002;70:3068–3072. doi: 10.1128/IAI.70.6.3068-3072.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 2000;1:199–205. doi: 10.1038/79734. [DOI] [PubMed] [Google Scholar]
  94. Muller C.A., Markovic-Lipkovski J., Klatt T., Gamper J., Schwarz G., Beck H., Deeg M., Kalbacher H., Widmann S., Wessels J.T., Becker V., Muller G.A., Flad T. Human alpha-defensins HNPs-1,-2, and-3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol. 2002;160:1311–1324. doi: 10.1016/s0002-9440(10)62558-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Murakami M., Ohtake T., Dorschner R.A., Gallo R.L. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res. 2002;81:845–850. doi: 10.1177/154405910208101210. [DOI] [PubMed] [Google Scholar]
  96. Murakami M., Ohtake T., Dorschner R.A., Schittek B., Garbe C., Gallo R.L. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol. 2002;119:1090–1095. doi: 10.1046/j.1523-1747.2002.19507.x. [DOI] [PubMed] [Google Scholar]
  97. Murakami M., Lopez-Garcia B., Braff M., Dorschner R.A., Gallo R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol. 2004;172:3070–3077. doi: 10.4049/jimmunol.172.5.3070. [DOI] [PubMed] [Google Scholar]
  98. Murakami M., Dorschner R.A., Stern L.J., Lin K.H., Gallo R.L. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr Res. 2005;57:10–15. doi: 10.1203/01.PDR.0000148068.32201.50. [DOI] [PubMed] [Google Scholar]
  99. Murphy C.J., Foster B.A., Mannis M.J., Selsted M.E., Reid T.W. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol. 1993;155:408–413. doi: 10.1002/jcp.1041550223. [DOI] [PubMed] [Google Scholar]
  100. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol. 2001;167:3329–3338. doi: 10.4049/jimmunol.167.6.3329. [DOI] [PubMed] [Google Scholar]
  101. Nagaoka I., Hirota S., Yomogida S., Ohwada A., Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res. 2000;49:73–79. doi: 10.1007/s000110050561. [DOI] [PubMed] [Google Scholar]
  102. Naik S., Kelly E.J., Meijer L., Pettersson S., Sanderson I.R. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr. 2001;32:449–453. doi: 10.1097/00005176-200104000-00011. [DOI] [PubMed] [Google Scholar]
  103. Nell M.J., Sandra Tjabringa G., Vonk M.J., Hiemstra P.S., Grote J.J. Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells. FEMS Immunol Med Microbiol. 2004;42:225–231. doi: 10.1016/j.femsim.2004.05.013. [DOI] [PubMed] [Google Scholar]
  104. Nishimura E., Eto A., Kato M., Hashizume S., Imai S., Nisizawa T., Hanada N. Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci. Curr Microbiol. 2004;48:85–87. doi: 10.1007/s00284-003-4108-3. [DOI] [PubMed] [Google Scholar]
  105. Nishimura M., Abiko Y., Kurashige Y., Takeshima M., Yamazaki M., Kusano K., Saitoh M., Nakashima K., Inoue T., Kaku T. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J Dermatol Sci. 2004;36:87–95. doi: 10.1016/j.jdermsci.2004.07.001. [DOI] [PubMed] [Google Scholar]
  106. Niyonsaba F., Someya A., Hirata M., Ogawa H., Nagaoka I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production frommast cells. Eur J Immunol. 2001;31:1066–1075. doi: 10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  107. Niyonsaba F., Iwabuchi K., Matsuda H., Ogawa H., Nagaoka I. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol. 2002;14:421–426. doi: 10.1093/intimm/14.4.421. [DOI] [PubMed] [Google Scholar]
  108. Niyonsaba F., Iwabuchi K., Someya A., Hirata M., Matsuda H., Ogawa H., Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology. 2002;106:20–26. doi: 10.1046/j.1365-2567.2002.01398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Niyonsaba F., Hirata M., Ogawa H., Nagaoka I. Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. Curr Drug Targets Inflamm Allergy. 2003;2:224–231. doi: 10.2174/1568010033484115. [DOI] [PubMed] [Google Scholar]
  110. Niyonsaba F., Ogawa H., Nagaoka I. Humanbeta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology. 2004;111:273–281. doi: 10.1111/j.0019-2805.2004.01816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 2001;414:454–457. doi: 10.1038/35106587. [DOI] [PubMed] [Google Scholar]
  112. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., Darst M.A., Gao B., Boguniewicz M., Travers J.B., Leung D.Y. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003;171:3262–3269. doi: 10.4049/jimmunol.171.6.3262. [DOI] [PubMed] [Google Scholar]
  113. Nyberg P., Rasmussen M., Bjorck L. Alpha 2-macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem. 2004;279:52820–52823. doi: 10.1074/jbc.C400485200. [DOI] [PubMed] [Google Scholar]
  114. Ogushi K., Wada A., Niidome T., Mori N., Oishi K., Nagatake T., Takahashi A., Asakura H., Makino S., Hojo H., Nakahara Y., Ohsaki M., Hatakeyama T., Aoyagi H., Kurazono H., Moss J., Hirayama T. Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. J Biol Chem. 2001;276:30521–30526. doi: 10.1074/jbc.M011618200. [DOI] [PubMed] [Google Scholar]
  115. Ohgami K., Ilieva I.B., Shiratori K., Isogai E., Yoshida K., Kotake S., Nishida T., Mizuki N., Ohno S. Effect of human cationic antimicrobial protein 18 peptide on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2003;44:4412–4418. doi: 10.1167/iovs.03-0246. [DOI] [PubMed] [Google Scholar]
  116. O’Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163:6718–6724. [PubMed] [Google Scholar]
  117. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160. doi: 10.1056/NEJMoa021481. [DOI] [PubMed] [Google Scholar]
  118. Palfree R.G., Sadro L.C., Solomon S. The gene encoding the human corticostatin HP-4 precursor contains a recent 86-base duplication and is located on chromosome 8. Mol Endocrinol. 1993;7:199–205. doi: 10.1210/mend.7.2.8469233. [DOI] [PubMed] [Google Scholar]
  119. Panyutich A.V., Panyutich E.A., Krapivin V.A., Baturevich E.A., Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993;122:202–207. [PubMed] [Google Scholar]
  120. Parmley R.T., Gilbert C.S., Boxer L.A. Abnormal peroxidase-positive granules in “specific granule” deficiency. Blood. 1989;73:838–844. [PubMed] [Google Scholar]
  121. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003;299:1033–1036. doi: 10.1126/science.1078231. [DOI] [PubMed] [Google Scholar]
  122. Perregaux D.G., Bhavsar K., Contillo L., Shi J., Gabel C.A. Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity. J Immunol. 2002;168:3024–3032. doi: 10.4049/jimmunol.168.6.3024. [DOI] [PubMed] [Google Scholar]
  123. Pulendran B., Banchereau J., Maraskovsky E., Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 2001;22:41–47. doi: 10.1016/s1471-4906(00)01794-4. [DOI] [PubMed] [Google Scholar]
  124. Putsep K., Axelsson L.G., Boman A., Midtvedt T., Normark S., Boman H.G., Andersson M. Germ-free and colonized mice generate the same products from enteric prodefensins. J Biol Chem. 2000;275:40478–40482. doi: 10.1074/jbc.M007816200. [DOI] [PubMed] [Google Scholar]
  125. Putsep K., Carlsson G., Boman H.G., Andersson M. Deficiency of antibacterial peptides in patients withmorbus Kostmann: an observation study. Lancet. 2002;360:1144–1149. doi: 10.1016/S0140-6736(02)11201-3. [DOI] [PubMed] [Google Scholar]
  126. Quayle A.J., Porter E.M., Nussbaum A.A., Wang Y.M., Brabec C., Yip K.P., Mok S.C. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol. 1998;152:1247–1258. [PMC free article] [PubMed] [Google Scholar]
  127. Ross D.J., Cole A.M., Yoshioka D., Park A.K., Belperio J.A., Laks H., Strieter R.M., Lynch J.P., 3rd, Kubak B., Ardehali A., Ganz T. Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2004;78:1222–1224. doi: 10.1097/01.tp.0000137265.18491.75. [DOI] [PubMed] [Google Scholar]
  128. Sakamoto N., Mukae H., Fujii T., Ishii H., Yoshioka S., Kakugawa T., Sugiyama K., Mizuta Y., Kadota J.I., Nakazato M., Kohno S. Differential effects of alpha-and betadefensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:L508–L513. doi: 10.1152/ajplung.00076.2004. [DOI] [PubMed] [Google Scholar]
  129. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422:522–526. doi: 10.1038/nature01520. [DOI] [PubMed] [Google Scholar]
  130. Sawa T., Kurahashi K., Ohara M., Gropper M.A., Doshi V., Larrick J.W., Wiener-Kronish J.P. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob Agents Chemother. 1998;42:3269–3275. doi: 10.1128/aac.42.12.3269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Sawyer J.G., Martin N.L., Hancock R.E. Interaction ofmacrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun. 1988;56:693–698. doi: 10.1128/iai.56.3.693-698.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., Casavant T.L., Mc-Cray P.B., Jr Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A. 2002;99:2129–2133. doi: 10.1073/pnas.042692699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol. 2002;169:3883–3891. doi: 10.4049/jimmunol.169.7.3883. [DOI] [PubMed] [Google Scholar]
  134. Scott M.G., Vreugdenhil A.C., Buurman W.A., Hancock R.E., Gold M.R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol. 2000;164:549–553. doi: 10.4049/jimmunol.164.2.549. [DOI] [PubMed] [Google Scholar]
  135. Selsted M.E., Harwig S.S., Ganz T., Schilling J.W., Lehrer R.I. Primary structures of three human neutrophil defensins. J Clin Invest. 1985;76:1436–1439. doi: 10.1172/JCI112121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Singh A., Bateman A., Zhu Q.Z., Shimasaki S., Esch F., Solomon S. Structure of a novel human granulocyte peptide with anti-ACTH activity. Biochem Biophys Res Commun. 1988;155:524–529. doi: 10.1016/s0006-291x(88)81118-5. [DOI] [PubMed] [Google Scholar]
  137. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., Greenberg E.P., Valore E.V., Welsh M.J., Ganz T., Tack B.F., McCray P.B., Jr Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A. 1998;95:14961–14966. doi: 10.1073/pnas.95.25.14961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Singh P.K., Tack B.F., McCray P.B., Jr, Welsh M.J. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol. 2000;279:L799–L805. doi: 10.1152/ajplung.2000.279.5.L799. [DOI] [PubMed] [Google Scholar]
  139. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97:3951–3959. doi: 10.1182/blood.v97.12.3951. [DOI] [PubMed] [Google Scholar]
  140. Sorensen O.E., Gram L., Johnsen A.H., Andersson E., Bangsboll S., Tjabringa G.S., Hiemstra P.S., Malm J., Egesten A., Borregaard N. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem. 2003;278:28540–28546. doi: 10.1074/jbc.M301608200. [DOI] [PubMed] [Google Scholar]
  141. Sparkes R.S., Kronenberg M., Heinzmann C., Daher K.A., Klisak I., Ganz T., Mohandas T. Assignment of defensin gene(s) to human chromosome 8p23. Genomics. 1989;5:240–244. doi: 10.1016/0888-7543(89)90052-9. [DOI] [PubMed] [Google Scholar]
  142. Spencer L.T., Paone G., Krein P.M., Rouhani F.N., Rivera-Nieves J., Brantly M.L. The role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol. 2003;286:L514–520. doi: 10.1152/ajplung.00099.2003. [DOI] [PubMed] [Google Scholar]
  143. Tamamura H., Imai M., Ishihara T., Masuda M., Funakoshi H., Oyake H., Murakami T., Arakaki R., Nakashima H., Otaka A., Ibuka T., Waki M., Matsumoto A., Yamamoto N., Fujii N. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection. Bioorg Med Chem. 1998;6:1033–1041. doi: 10.1016/s0968-0896(98)00061-3. [DOI] [PubMed] [Google Scholar]
  144. Tanaka D., Miyasaki K.T., Lehrer R.I. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol. 2000;15:226–231. doi: 10.1034/j.1399-302x.2000.150403.x. [DOI] [PubMed] [Google Scholar]
  145. Tani K., Murphy W.J., Chertov O., Salcedo R., Koh C.Y., Utsunomiya I., Funakoshi S., Asai O., Herrmann S.H., Wang J.M., Kwak L.W., Oppenheim J.J. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol. 2000;12:691–700. doi: 10.1093/intimm/12.5.691. [DOI] [PubMed] [Google Scholar]
  146. Territo M.C., Ganz T., Selsted M.E., Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest. 1989;84:2017–2020. doi: 10.1172/JCI114394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Turner J., Cho Y., Dinh N.N., Waring A.J., Lehrer R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998;42:2206–2214. doi: 10.1128/aac.42.9.2206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Van Wetering S., Mannesse-Lazeroms S.P., Van Sterkenburg M.A., Daha M.R., Dijkman J.H., Hiemstra P.S. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol. 1997;272:L888–L896. doi: 10.1152/ajplung.1997.272.5.L888. [DOI] [PubMed] [Google Scholar]
  149. Van Wetering S., Mannesse-Lazeroms S.P., van Sterkenburg M.A., Hiemstra P.S. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res. 2002;51:8–15. doi: 10.1007/pl00000282. [DOI] [PubMed] [Google Scholar]
  150. VanderMeer T.J., Menconi M.J., Zhuang J., Wang H., Murtaugh R., Bouza C., Stevens P., Fink M.P. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. Surgery. 1995;117:656–662. doi: 10.1016/s0039-6060(95)80009-3. [DOI] [PubMed] [Google Scholar]
  151. Vora P., Youdim A., Thomas L.S., Fukata M., Tesfay S.Y., Lukasek K., Michelsen K.S., Wada A., Hirayama T., Arditi M., Abreu M.T. β-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol. 2004;173:5398–5405. doi: 10.4049/jimmunol.173.9.5398. [DOI] [PubMed] [Google Scholar]
  152. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–2912. doi: 10.4049/jimmunol.173.5.2909. [DOI] [PubMed] [Google Scholar]
  153. Wang Y., Agerberth B., Lothgren A., Almstedt A., Johansson J. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem. 1998;273:33115–33118. doi: 10.1074/jbc.273.50.33115. [DOI] [PubMed] [Google Scholar]
  154. Wehkamp J., Schmidt K., Herrlinger K.R., Baxmann S., Behling S., Wohlschlager C., Feller A.C., Stange E.F., Fellermann K. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol. 2003;56:352–357. doi: 10.1136/jcp.56.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans. 2003;31:785–790. doi: 10.1042/bst0310785. [DOI] [PubMed] [Google Scholar]
  156. Welling M.M., Hiemstra P.S., van den Barselaar M.T., Paulusma-Annema A., Nibbering P.H., Pauwels E.K., Calame W. Antibacterial activity of human neutrophil defensins in experimental infections inmice is accompanied by increased leukocyte accumulation. J Clin Invest. 1998;102:1583–1590. doi: 10.1172/JCI3664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. White S.H., Wimley W.C., Selsted M.E. Structure, function, and membrane integration of defensins. Curr Opin Struct Biol. 1995;5:521–527. doi: 10.1016/0959-440x(95)80038-7. [DOI] [PubMed] [Google Scholar]
  158. Wilde C.G., Griffith J.E., Marra M.N., Snable J.L., Scott R.W. Purification and characterization of human neutrophil peptide 4, a novelmember of the defensin family. J Biol Chem. 1989;264:11200–11203. [PubMed] [Google Scholar]
  159. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., Lopez-Boado Y.S., Stratman J.L., Hultgren S.J., Matrisian L.M., Parks W.C. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 1999;286:113–117. doi: 10.1126/science.286.5437.113. [DOI] [PubMed] [Google Scholar]
  160. Yan H., Hancock R.E. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother. 2001;45:1558–1560. doi: 10.1128/AAC.45.5.1558-1560.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286:525–528. doi: 10.1126/science.286.5439.525. [DOI] [PubMed] [Google Scholar]
  162. Yang D., Chen Q., Chertov O., Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol. 2000;68:9–14. [PubMed] [Google Scholar]
  163. Yang D., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069–1074. doi: 10.1084/jem.192.7.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. defensins in immunity: more than just microbicidal. Trends Immunol. 2002;23:291–296. doi: 10.1016/s1471-4906(02)02246-9. [DOI] [PubMed] [Google Scholar]
  165. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., Oppenheim J.J. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol. 2003;74:448–455. doi: 10.1189/jlb.0103024. [DOI] [PubMed] [Google Scholar]
  166. Zaiou M., Nizet V., Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol. 2003;120:810–816. doi: 10.1046/j.1523-1747.2003.12132.x. [DOI] [PubMed] [Google Scholar]
  167. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39–48. doi: 10.1189/jlb.0403147. [DOI] [PubMed] [Google Scholar]
  168. Zhang H., Downey G.P., Suter P.M., Slutsky A.S., Ranieri V.M. Conventional mechanical ventilation is associated with bronchoalveolar lavage-induced activation of polymorphonuclear leukocytes: a possible mechanism to explain the systemic consequences of ventilator-induced lung injury in patients with ARDS. Anesthesiology. 2002;97:1426–1433. doi: 10.1097/00000542-200212000-00014. [DOI] [PubMed] [Google Scholar]
  169. Zhang K., Lu Q., Zhang Q., Hu X. Regulation of activities of NK cells and CD4 expression in T cells by human HNP-1,-2, and-3. Biochem Biophys Res Commun. 2004;323:437–444. doi: 10.1016/j.bbrc.2004.08.111. [DOI] [PubMed] [Google Scholar]
  170. Zhao C., Wang I., Lehrer R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996;396:319–322. doi: 10.1016/0014-5793(96)01123-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Peptides and Human Disease are provided here courtesy of Nature Publishing Group

RESOURCES